Dale Hoekema, MD in Anchorage, AK - Medicare Critical Care (intensivists)

Dale Hoekema, MD is a medicare enrolled "Internal Medicine - Critical Care Medicine" physician in Anchorage, Alaska. He went to University Of Washington School Of Medicine and graduated in 1982 and has 42 years of diverse experience with area of expertise as Critical Care (intensivists). He is a member of the group practice Rcch Trios Health Llc and his current practice location is 4300 B St Ste 200, Anchorage, Alaska. You can reach out to his office (for appointments etc.) via phone at (907) 375-3355.

Dale Hoekema is licensed to practice in Alaska (license number 126504) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1447207832.

Contact Information

	Dale Hoekema, MD
	4300 B St Ste 200, Anchorage, AK 99503-5933
	(907) 375-3355
	(907) 375-3351

Physician's Profile

Full Name	Dale Hoekema
Gender	Male
Speciality	Critical Care (intensivists)
Experience	42 Years
Location	4300 B St Ste 200, Anchorage, Alaska
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dale Hoekema attended and graduated from University Of Washington School Of Medicine in 1982

NPI Data:

NPI Number: 1447207832
Provider Enumeration Date: 05/30/2006
Last Update Date: 01/18/2018

Medicare PECOS Information:

PECOS PAC ID: 6709973712
Enrollment ID: I20100125000097

Medical Identifiers

Medical identifiers for Dale Hoekema such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1447207832	NPI	-	NPPES
025904	Other	WA	KRMC L&I GROUP #
140008346	Other	MS	RR MCR PTAN
140000142	Other	MS	2007 MCR
02136393	Medicaid	MS
1447207832	Medicaid	WA
P00634035	Other	MS	RAILROAD MEDICARE

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207R00000X	Internal Medicine	MD00020847 (Washington)	Secondary
207R00000X	Internal Medicine	16816 (Mississippi)	Secondary
208M00000X	Hospitalist	MD00020847 (Washington)	Secondary
207RC0200X	Internal Medicine - Critical Care Medicine	126504 (Alaska)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Trios Health	Kennewick, WA	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Rcch Trios Health Llc	5799035416	56

News Archive

Oncothyreon commences combination PX-866/cetuximab Phase 1/2 trial in cancers

Oncothyreon Inc. today announced enrollment of the first patient in a Phase 1/2 trial of PX-866 in combination with the chimeric monoclonal antibody cetuximab (Erbitux®). PX-866 is a small molecule compound designed to inhibit the activity of phosphatidylinositol-3-kinase (PI-3K), a component of an important cell survival signaling pathway.

Study identifies six risk factors associated with blindness after spine surgery

A study published in the January 2012 issue of Anesthesiology identified six risk factors associated with blindness or partial blindness that can occur after major spine surgery: 1) male sex, 2) obesity, 3) use of a surgical frame that places the head lower than the heart, 4) length of the surgery, 5) amount of blood loss and 6) use of certain fluids that replace lost blood.

Positive interim data from Phase I/II trial of CYT387 in myelofibrosis presented at ASH Annual Meeting

YM BioSciences Inc. today announced positive interim data from the first 60 patients enrolled in the Phase I/II trial for its JAK1/JAK2 inhibitor, CYT387, in myelofibrosis. The results were reported today in an oral presentation at the 52nd American Society of Hematology Annual Meeting being held in Orlando, Florida.

Antibiotics could be preventing thousands of deaths a year in intensive care units worldwide

Trials done in over 7,000 people prove conclusively that antibiotics could prevent deaths in intensive care units, but many hospitals aren't using them because of unproven fears that it might increase antibiotic resistance.

Scientists use graphene to target, neutralise cancer stem cells

University of Manchester scientists have used graphene to target and neutralise cancer stem cells while not harming other cells.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dale Hoekema allows following entities to bill medicare on his behalf.

Entity Name	Rcch Trios Health Llc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1831682806 PECOS PAC ID: 5799035416 Enrollment ID: O20180830000618

News Archive

Oncothyreon commences combination PX-866/cetuximab Phase 1/2 trial in cancers

Study identifies six risk factors associated with blindness after spine surgery

Positive interim data from Phase I/II trial of CYT387 in myelofibrosis presented at ASH Annual Meeting

Antibiotics could be preventing thousands of deaths a year in intensive care units worldwide

Scientists use graphene to target, neutralise cancer stem cells

University of Manchester scientists have used graphene to target and neutralise cancer stem cells while not harming other cells.

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dale Hoekema is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dale Hoekema, MD 3900 S Zintel Way, Kennewick, WA 99337-5092 Ph: (509) 942-3627	Dale Hoekema, MD 4300 B St Ste 200, Anchorage, AK 99503-5933 Ph: (907) 375-3355

News Archive

Oncothyreon commences combination PX-866/cetuximab Phase 1/2 trial in cancers

Study identifies six risk factors associated with blindness after spine surgery

Positive interim data from Phase I/II trial of CYT387 in myelofibrosis presented at ASH Annual Meeting

Antibiotics could be preventing thousands of deaths a year in intensive care units worldwide

Scientists use graphene to target, neutralise cancer stem cells

University of Manchester scientists have used graphene to target and neutralise cancer stem cells while not harming other cells.

Internal Medicine Doctors in Anchorage, AK

Andrea Caballero, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 3220 Providence Dr Ste E3-080, Anchorage, AK 99508 Phone: 907-375-8785 Fax: 907-375-8788
Daryl M. Mcclendon, M.D., P.C. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 3851 Piper Street, Suite U466, Anchorage, AK 99508 Phone: 907-569-1333 Fax: 907-569-1433
Dr. Loretta Leih-sheng Lee, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 4001 Dale St, Suite 210, Anchorage, AK 99508 Phone: 907-929-5880 Fax: 907-929-5882
Dr. Richard Merle Farleigh, M.D. Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 4120 Laurel St, Suite 202, Anchorage, AK 99508 Phone: 907-561-4293
Alexis Leandro Delgado, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 4300 B St, Suite 200, Anchorage, AK 99503 Phone: 907-375-3355 Fax: 907-375-3351
Geronimo Sahagun, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 2841 Debarr Road, Suite 50, Anchorage, AK 99508 Phone: 907-276-2811 Fax: 907-276-2810
Dr. Tram Phuong Chu, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 3200 Providence Dr, Suite B111, Anchorage, AK 99508 Phone: 907-212-7890 Fax: 907-212-2374

Dale Hoekema, MD - Medicare Critical Care (intensivists) in Anchorage, AK

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

Oncothyreon commences combination PX-866/cetuximab Phase 1/2 trial in cancers

Study identifies six risk factors associated with blindness after spine surgery

Positive interim data from Phase I/II trial of CYT387 in myelofibrosis presented at ASH Annual Meeting

Antibiotics could be preventing thousands of deaths a year in intensive care units worldwide

Scientists use graphene to target, neutralise cancer stem cells

Medicare Reassignments

Oncothyreon commences combination PX-866/cetuximab Phase 1/2 trial in cancers

Study identifies six risk factors associated with blindness after spine surgery

Positive interim data from Phase I/II trial of CYT387 in myelofibrosis presented at ASH Annual Meeting

Antibiotics could be preventing thousands of deaths a year in intensive care units worldwide

Scientists use graphene to target, neutralise cancer stem cells

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Oncothyreon commences combination PX-866/cetuximab Phase 1/2 trial in cancers

Study identifies six risk factors associated with blindness after spine surgery

Positive interim data from Phase I/II trial of CYT387 in myelofibrosis presented at ASH Annual Meeting

Antibiotics could be preventing thousands of deaths a year in intensive care units worldwide

Scientists use graphene to target, neutralise cancer stem cells

Internal Medicine Doctors in Anchorage, AK